Medipharm Labs Corp (LABS) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.004x

Based on the latest financial reports, Medipharm Labs Corp (LABS) has a cash flow conversion efficiency ratio of -0.004x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-158.00K ≈ $-114.29K USD) by net assets (CA$37.86 Million ≈ $27.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Medipharm Labs Corp - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Medipharm Labs Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Medipharm Labs Corp carry for a breakdown of total debt and financial obligations.

Medipharm Labs Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medipharm Labs Corp ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Blue Star Gold Corp V:BAU	-0.270x
ECM Libra Financial Group Bhd KLSE:2143	0.020x
Bflysoft Co. Ltd. KQ:148780	0.134x
CryoCell International Inc NYSE MKT:CCEL	-0.171x
Above Food Ingredients Inc. Common Stock NASDAQ:ABVE	0.000x
HydrogenPro AS OL:HYPRO	-0.165x
Verena Multi Finance Tbk JK:VRNA	0.085x
Investors House HE:INVEST	0.029x

Annual Cash Flow Conversion Efficiency for Medipharm Labs Corp (2016–2024)

The table below shows the annual cash flow conversion efficiency of Medipharm Labs Corp from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see Medipharm Labs Corp stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$43.18 Million ≈ $31.24 Million	CA$-4.86 Million ≈ $-3.52 Million	-0.113x	+51.65%
2023-12-31	CA$53.01 Million ≈ $38.34 Million	CA$-12.34 Million ≈ $-8.93 Million	-0.233x	+18.87%
2022-12-31	CA$56.01 Million ≈ $40.51 Million	CA$-16.07 Million ≈ $-11.62 Million	-0.287x	-80.55%
2021-12-31	CA$83.15 Million ≈ $60.15 Million	CA$-13.21 Million ≈ $-9.56 Million	-0.159x	+67.01%
2020-12-31	CA$78.41 Million ≈ $56.72 Million	CA$-37.77 Million ≈ $-27.32 Million	-0.482x	-150.20%
2019-12-31	CA$131.23 Million ≈ $94.93 Million	CA$-25.27 Million ≈ $-18.28 Million	-0.193x	+51.76%
2018-12-31	CA$27.84 Million ≈ $20.14 Million	CA$-11.11 Million ≈ $-8.04 Million	-0.399x	-410.70%
2017-12-31	CA$-2.12 Million ≈ $-1.54 Million	CA$166.00K ≈ $120.08K	-0.078x	+69.21%
2016-12-31	CA$215.46K ≈ $155.86K	CA$-54.69K ≈ $-39.56K	-0.254x	--

About Medipharm Labs Corp

TO:LABS Canada Drug Manufacturers - Specialty & Generic

Market Cap

$27.39 Million

CA$37.87 Million CAD

Market Cap Rank

#24016 Global

#908 in Canada

Share Price

CA$0.09

Change (1 day)

+0.00%

52-Week Range

CA$0.06 - CA$0.10

All Time High

CA$7.17